Kimi Iguchi

2021

In 2021, Kimi Iguchi earned a total compensation of $2.4M as Chief Financial Officer and Treasurer at Sage Therapeutics, a 23% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$167,473
Option Awards$1,021,180
Salary$443,049
Stock Awards$781,565
Other$10,651
Total$2,423,918

Iguchi received $1M in option awards, accounting for 42% of the total pay in 2021.

Iguchi also received $167.5K in non-equity incentive plan, $443K in salary, $781.6K in stock awards and $10.7K in other compensation.

Rankings

In 2021, Kimi Iguchi's compensation ranked 5,270th out of 12,415 executives tracked by ExecPay. In other words, Iguchi earned more than 57.6% of executives.

ClassificationRankingPercentile
All
5,270
out of 12,415
58th
Division
Manufacturing
2,219
out of 5,505
60th
Major group
Chemicals And Allied Products
967
out of 2,375
59th
Industry group
Drugs
862
out of 2,096
59th
Industry
Pharmaceutical Preparations
620
out of 1,546
60th

Pay ratio

Kimi Iguchi's Pay$2,423,918
Median Employee's Pay$308,210
Pay Ratio

8

to 1

In 2021, the annual total compensation of Kimi Iguchi was $2,423,918.

The annual total compensation of the median employee at Sage Therapeutics was $308,210.

The ratio of Kimi Iguchi's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 28, 2022.

Iguchi's colleagues

We found four more compensation records of executives who worked with Kimi Iguchi at Sage Therapeutics in 2021.

2021

Barry Greene

Sage Therapeutics

Chief Executive Officer

2021

Jeffrey Jonas

Sage Therapeutics

Chief Innovation Officer

2021

Albert Robichaud

Sage Therapeutics

Chief Scientific Officer

2021

Christopher Benecchi

Sage Therapeutics

Chief Commercial Officer

News

You may also like